Intracavernous Growth Differentiation Factor-5 Therapy Enhances the Recovery of Erectile Function in a Rat Model of Cavernous Nerve Injury
Authors:
- 1 August 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 5 (8) , 1866-1875
Abstract
Introduction Neurogenic erectile dysfunction remains a serious complication in the postprostatectomy population. Effective protective and regenerative neuromodulatory strategies are needed. Aim To determine the effect of growth differentiation factor‐5 (GDF‐5) on erectile function and its mechanism in a rat model of cavernous nerve (CN) injury. Main Outcome Measures Erectile function was assessed by CN electrostimulation at 4 weeks. Penile tissues were examined by real‐time polymerase chain reaction (PCR) and immunohistochemical analyses. Methods Forty‐eight male Sprague‐Dawley rats were randomly divided into six equal groups: one group underwent sham operation (uninjured controls), while five groups underwent bilateral CN crush. Crush‐injury groups were treated at the time of injury with intracavernous injection of a slow‐release suspension of liquid microparticles containing no GDF‐5 (vehicle), 0.4 µg (low concentration), 2 µg (intermediate concentration), or 10 µg GDF‐5 (high concentration). One untreated group served as injured controls. Results GDF‐5 enhanced erectile recovery and significantly increased intracavernous pressure in the low and intermediate‐concentration groups vs. injured controls. Low‐concentration GDF‐5 demonstrated the best functional preservation, as the intracavernous pressure increase in this group did not differ significantly from uninjured controls. A dose‐response relationship was confirmed for the effects of GDF‐5 in penile tissue. Low‐concentration GDF‐5 showed better preservation of the penile dorsal nerves and antiapoptotic effects in the corpus cavernosum (P < 0.05 vs. injured controls). Although high concentration GDF‐5 did not confer meaningful erectile recovery, this dose was more effective at decreasing transforming growth factor‐β than low‐concentration GDF‐5. Conclusion Intracavernous injection of low (0.4 µg) or intermediate‐concentration GDF‐5 (2 µg) was effective in preserving erectile function in a rat model of neurogenic erectile dysfunction. The underlying mechanism appears to involve neuron preservation and antiapoptosis. Fandel TM, Bella AJ, Lin G, Tantiwongse K, Lin C‐S, Pohl J, and Lue TF. Intracavernous growth differentiation factor‐5 therapy enhances the recovery of erectile function in a rat model of cavernous nerve injury. J Sex Med 2008;5:1866–1875.Keywords
This publication has 35 references indexed in Scilit:
- Penile Rehabilitation After Radical Prostatectomy: Where Do We Stand and Where are We Going?The Journal of Sexual Medicine, 2007
- Healos/Recombinant Human Growth and Differentiation Factor-5 Induces Posterolateral Lumbar Fusion in a New Zealand White Rabbit ModelSpine, 2006
- Neuromodulatory Therapy to Improve Erectile Function Recovery Outcomes After Pelvic SurgeryJournal of Urology, 2006
- The effect of intracavernosal growth differentiation factor‐5 therapy in a rat model of cavernosal nerve injuryBJU International, 2006
- Prediction of Postoperative Sexual Function After Nerve Sparing Radical Retropubic ProstatectomyJournal of Urology, 2006
- Combination of engineered neural cell adhesion molecules and GDF-5 for improved neurite extension in nerve guide conceptsBiomaterials, 2006
- The role of growth/differentiation factor 5 (GDF5) in the induction and survival of midbrain dopaminergic neurones: relevance to Parkinson's disease treatmentJournal of Anatomy, 2005
- Characterization of growth/differentiation factor 5 (GDF-5) as a neurotrophic factor for cultured neurons from chicken dorsal root gangliaNeuroscience Letters, 1997
- Trophic and protective effects of growth/differentiation factor 5, a member of the transforming growth factor‐β superfamily, on midbrain dopaminergic neuronsJournal of Neuroscience Research, 1995
- Cloning and Expression of Recombinant Human Growth/Differentiation Factor 5Biochemical and Biophysical Research Communications, 1994